1. A.S. Ermolov S.V. Smirnov T.G. Spiridonova et al.2001 Endogenous intoxication as the leading cause of acute gastroduodenal haemorrhages in burn patients Ann Furns and Fire Disasters XIV 3 119 126.

1. A.S. Ermolov S.V. Smirnov T.G. Spiridonova 2001 Endogenous intoxication as the leading cause of acute gastroduodenal haemorrhages in burn patients Ann Furns and Fire Disasters XIV 3 119 126.)| false
• Search Google Scholar
• Export Citation

2. S.G. Galaktionov V.V. Nikolaichik V.M. Tseitin et al.1983 “Middle molecules” — Endotoxins of peptide nature Pharmaceut Chem J 17 11 759 765.

2. S.G. Galaktionov V.V. Nikolaichik V.M. Tseitin 1983 “Middle molecules” — Endotoxins of peptide nature Pharmaceut Chem J 17 11 759 765.)| false
• Search Google Scholar
• Export Citation

3. H.T. Mendonca-Filho K.C. Pereira M. Fontes et al.2006 Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study Crit Care 10 2 R46.

3. H.T. Mendonca-Filho K.C. Pereira M. Fontes 2006 Circulating inflammatory mediators and organ dysfunction after cardiovascular surgery with cardiopulmonary bypass: a prospective observational study Crit Care 10 2 R46.)| false
• Search Google Scholar
• Export Citation

4. J.H. Holmes N.C. Connolly D. Paull et al.2002 Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes Inflamm Res 51 12 579 586.

4. J.H. Holmes N.C. Connolly D. Paull 2002 Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes Inflamm Res 51 12 579 586.)| false
• Search Google Scholar
• Export Citation

5. J. Butler G. Rocker S. Westaby 1993 Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 55 552 559.

5. J. Butler G. Rocker S. Westaby 1993 Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 55 552 559.)| false
• Search Google Scholar
• Export Citation

6. D. Nebert T. Dalton 2006 The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis Nat Rev Cancer 6 947 960.

6. D. Nebert T. Dalton 2006 The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis Nat Rev Cancer 6 947 960.)| false
• Search Google Scholar
• Export Citation

7. B. Harbrecht R. Frye M. Zenati 2005 Cytochrome P-450 activity is differentially altered in severely injured patients Crit Care Med 33 541 546.

7. B. Harbrecht R. Frye M. Zenati 2005 Cytochrome P-450 activity is differentially altered in severely injured patients Crit Care Med 33 541 546.)| false
• Search Google Scholar
• Export Citation

8. E. Siewert R. Bort R. Kluge 2000 Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent Hepatology 32 49 55.

8. E. Siewert R. Bort R. Kluge 2000 Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent Hepatology 32 49 55.)| false
• Search Google Scholar
• Export Citation

9. R. Frye V. Schneider C. Frye et al.2002 Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure J Card Fail 8 5 315 319.

9. R. Frye V. Schneider C. Frye 2002 Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure J Card Fail 8 5 315 319.)| false
• Search Google Scholar
• Export Citation

10. J. Carcillo L. Dougty D. Kofos et al.2003 Cytochrome P450 mediateddrug metabolism is reduced in children with sepsis-induced multiple organ failure Intensive Care Med 29 6 980 984.

10. J. Carcillo L. Dougty D. Kofos 2003 Cytochrome P450 mediateddrug metabolism is reduced in children with sepsis-induced multiple organ failure Intensive Care Med 29 6 980 984.)| false
• Search Google Scholar
• Export Citation

11. V.A. Nepomniashchikh V.V. Lomivorotov M.N. Deryagin et al.2009 Oxidative stress and monooxygenase liver function in patients with coronary heart disease and multiple organ dysfunction syndrome Eur J Anaesthesiol 26 2 140 146.

11. V.A. Nepomniashchikh V.V. Lomivorotov M.N. Deryagin 2009 Oxidative stress and monooxygenase liver function in patients with coronary heart disease and multiple organ dysfunction syndrome Eur J Anaesthesiol 26 2 140 146.)| false
• Search Google Scholar
• Export Citation

12. J. Vincent 1997 Organ dysfunction as an outcome measure: The SOFA Score Sepsis 1 1 53 54.

12. J. Vincent 1997 Organ dysfunction as an outcome measure: The SOFA Score Sepsis 1 1 53 54.)| false
• Search Google Scholar
• Export Citation

13. N.I. Gabrielian V.I. Lipatova 1984 The experience of data on middle molecules in blood for diagnosis of nephrological diseases in children Lab Work 3 138 140.

13. N.I. Gabrielian V.I. Lipatova 1984 The experience of data on middle molecules in blood for diagnosis of nephrological diseases in children Lab Work 3 138 140.)| false
• Search Google Scholar
• Export Citation

14. J. Winchester P. Audia 2006 Extracorporeal strategies for the removal of middle molecules Semin Dial 19 110 114.

14. J. Winchester P. Audia 2006 Extracorporeal strategies for the removal of middle molecules Semin Dial 19 110 114.)| false
• Search Google Scholar
• Export Citation

15. W. Clark J. Winchester 2003 Middle molecules and small-molecular-weight proteins in ESRD: properties and strategies for their removal Adv Ren Replace Ther 10 270 278.

15. W. Clark J. Winchester 2003 Middle molecules and small-molecular-weight proteins in ESRD: properties and strategies for their removal Adv Ren Replace Ther 10 270 278.)| false
• Search Google Scholar
• Export Citation

16. E. Tanaka D. Breimer 1997 In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease J Clin Pharm Ther 22 4 237 249.

16. E. Tanaka D. Breimer 1997 In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease J Clin Pharm Ther 22 4 237 249.)| false
• Search Google Scholar
• Export Citation

17. S. Nedelkina I. Dianova R. Subbotina et al.1977 Indirect method for determination liver drug metabolism ferments and its clinical application Questions Med Chem 6 844 847.

17. S. Nedelkina I. Dianova R. Subbotina 1977 Indirect method for determination liver drug metabolism ferments and its clinical application Questions Med Chem 6 844 847.)| false
• Search Google Scholar
• Export Citation

18. D. Nebert D. Russell 2002 Clinical importance of the cytochromes P450 Lancet 360 1155 1162.

18. D. Nebert D. Russell 2002 Clinical importance of the cytochromes P450 Lancet 360 1155 1162.)| false
• Search Google Scholar
• Export Citation

19. A. Sarkis R. Roman 2004 Role of cytochrome P450 metabolites of arachidonic acid in hypertension Curr Drug Metab 5 3 245 256.

19. A. Sarkis R. Roman 2004 Role of cytochrome P450 metabolites of arachidonic acid in hypertension Curr Drug Metab 5 3 245 256.)| false
• Search Google Scholar
• Export Citation

20. D. Sacerdoti A. Gatta J. McGiff 2003 Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology Prostaglandins Other Lipid Mediat 72 1–2 51 71.

20. D. Sacerdoti A. Gatta J. McGiff 2003 Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology Prostaglandins Other Lipid Mediat 72 1–2 51 71.)| false
• Search Google Scholar
• Export Citation

21. J. Chiang 1998 Regulation of bile acid synthesis Front Biosci 15 3 D176 D193.

21. J. Chiang 1998 Regulation of bile acid synthesis Front Biosci 15 3 D176 D193.)| false
• Search Google Scholar
• Export Citation

22. A. Abu-Bakar M. Moore 2005 Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5 Biochem Pharmacol 70 10 1527 1535.

22. A. Abu-Bakar M. Moore 2005 Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5 Biochem Pharmacol 70 10 1527 1535.)| false
• Search Google Scholar
• Export Citation

23. F. De Matteis S. Dawson N. Pons et al.2002 Bilirubin and uroporphyrinogen oxidation by induced cytochrome P4501A and cytochrome P4502B. Role of polyhalogenated biphenyls of different configuration Biochem Pharmacol 63 4 615 624.

23. F. De Matteis S. Dawson N. Pons 2002 Bilirubin and uroporphyrinogen oxidation by induced cytochrome P4501A and cytochrome P4502B. Role of polyhalogenated biphenyls of different configuration Biochem Pharmacol 63 4 615 624.)| false
• Search Google Scholar
• Export Citation

24. C. Zaccaro S. Sweitzer S. Pipino et al.2001 Role of cytochrome P450 1A2 in bilirubin degradation. Studies in Cyp1a2 (−/−) mutant mice Biochem Pharmacol 61 7 843 849.

24. C. Zaccaro S. Sweitzer S. Pipino 2001 Role of cytochrome P450 1A2 in bilirubin degradation. Studies in Cyp1a2 (−/−) mutant mice Biochem Pharmacol 61 7 843 849.)| false
• Search Google Scholar
• Export Citation

25. E. Morgan 1997 Regulation of cytochromes P450 during inflammation and infection Drug Metab Rev 29 1129 1188.

25. E. Morgan 1997 Regulation of cytochromes P450 during inflammation and infection Drug Metab Rev 29 1129 1188.)| false
• Search Google Scholar
• Export Citation

26. S.H. Lee S.M. Lee 2005 Suppression of hepatic cytochrome P450-mediated drug metabolism during the late stage of sepsis in rats Shock 23 2 144 149.

26. S.H. Lee S.M. Lee 2005 Suppression of hepatic cytochrome P450-mediated drug metabolism during the late stage of sepsis in rats Shock 23 2 144 149.)| false
• Search Google Scholar
• Export Citation

27. F. Hinder H. Tubbe H. Van Aken H. Baba et al.2003 Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia Crit Care Med 31 3 903 909.

27. F. Hinder H. Tubbe H. Van Aken H. Baba 2003 Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia Crit Care Med 31 3 903 909.)| false
• Search Google Scholar
• Export Citation

28. J. Lin A. Lu 1998 Inhibition and induction of cytochrome P450 and the clinical implications Clin Pharmacokinet 35 5 361 390.

28. J. Lin A. Lu 1998 Inhibition and induction of cytochrome P450 and the clinical implications Clin Pharmacokinet 35 5 361 390.)| false
• Search Google Scholar
• Export Citation

29. A.A. Efimov V.A. Nepomniashchikh V.V. Lomivorotov et al.2007 Effect of phenobarbital on monooxygenase liver function in cardiac surgery patients with coronary artery disease Bulletin of Research Center on Cardiovascular Surgery named after AN Bakulev of RAMS 8 6 212.

29. A.A. Efimov V.A. Nepomniashchikh V.V. Lomivorotov 2007 Effect of phenobarbital on monooxygenase liver function in cardiac surgery patients with coronary artery disease Bulletin of Research Center on Cardiovascular Surgery named after AN Bakulev of RAMS 8 6 212.)| false
• Search Google Scholar
• Export Citation

30. V.A. Nepomniashchikh V.V. Lomivorotov M.N. Deryagin et al.2008 Intensification of lipid peroxidation and hepar metabolism in coronary heart disease patients with low ejection fraction Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences 1 71 76.

30. V.A. Nepomniashchikh V.V. Lomivorotov M.N. Deryagin 2008 Intensification of lipid peroxidation and hepar metabolism in coronary heart disease patients with low ejection fraction Bulletin of the Siberian Branch of the Russian Academy of Medical Sciences 1 71 76.)| false
• Search Google Scholar
• Export Citation